NAD+ — nicotinamide adenine dinucleotide — is one of the most important molecules in human biochemistry, and its decline with age is one of the most robust findings in the biology of aging research. NAD+ is required for the function of sirtuins (the longevity enzymes that regulate cellular health, s

The Most Important Molecule You Have Never Heard Of

NAD+ — nicotinamide adenine dinucleotide — is one of the most important molecules in human biochemistry, and its decline with age is one of the most robust findings in the biology of aging research. NAD+ is required for the function of sirtuins (the longevity enzymes that regulate cellular health, stress resistance, and metabolic function), for the repair of DNA damage (which accumulates with age and drives many of the cellular changes we associate with aging), and for the function of the electron transport chain in mitochondria (which generates the ATP that powers all cellular activity). Without NAD+, cells die. With declining NAD+, cellular function deteriorates in ways that manifest as fatigue, cognitive decline, metabolic dysfunction, and accelerated aging.

Why NAD+ Declines With Age

NAD+ declines with age primarily because it is consumed at a higher rate than it is synthesised. The enzyme that produces NAD+ — NMN adenylyl transferases (NMNATs) — becomes less efficient with age, while the enzymes that consume NAD+ — particularly PARPs (poly ADP-ribose polymerases, involved in DNA repair) and CD38/CD157 (immune cell enzymes involved in calcium signalling) — increase their activity with age, particularly in states of chronic inflammation. The net result is a progressive depletion of NAD+ that begins in the third decade and accelerates through middle age and beyond.

The consequences of NAD+ depletion are not abstract. Sirtuin activity requires NAD+, and sirtuins regulate cellular energy production, stress resistance, DNA repair, and inflammatory responses. When NAD+ falls, sirtuin activity falls, and these protective mechanisms are compromised. The mitochondria — which produce the ATP that powers all cellular activity — require NAD+ for the electron transport chain, and NAD+ depletion impairs mitochondrial function, contributing to the fatigue and reduced metabolic rate that characterise aging. In the brain, NAD+ decline is associated with impaired neuronal energy metabolism, reduced DNA repair capacity, and accelerated cognitive decline.

The NAD+ Precursor Approach

The solution to NAD+ decline is to provide the body with the raw materials to synthesise more NAD+. Several NAD+ precursor molecules have been studied: nicotinamide riboside (NR), nicotinamide mononucleotide (NMN), and nicotinamide (NAM). Both NR and NMN have been shown to elevate NAD+ levels in human trials, though the clinical benefits of supplementation in healthy younger adults are less clear than the benefits in older adults with established NAD+ depletion. The combination of NAD+ precursor supplementation with other mitochondrial support nutrients — CoQ10, PQQ, alpha-lipoic acid — represents the most evidence-based approach to addressing cellular energy decline.

What the Research Actually Shows

The evidence for NAD+ precursor supplementation is strongest in older adults with demonstrated NAD+ depletion, where improvements in energy, cognitive function, and metabolic parameters have been documented. In younger adults, the evidence is more preliminary — NAD+ levels improve, but whether this translates into meaningful clinical benefits is less established. This does not mean supplementation is unreasonable for younger adults; it means expectations should be calibrated appropriately. The most compelling use case is for people over 50 experiencing fatigue, cognitive decline, or metabolic dysfunction associated with aging.

This article is for informational purposes only.

Sirtuins and the Longevity Connection

Sirtuins are a family of enzymes that regulate cellular health, stress resistance, and metabolic function. There are seven sirtuin proteins in humans (SIRT1 through SIRT7), and they are activated by NAD+. When NAD+ levels are high, sirtuin activity increases, promoting cellular repair processes, improving mitochondrial function, increasing stress resistance, and reducing inflammation. When NAD+ levels decline — as they do with aging — sirtuin activity decreases, and these protective functions are compromised. The sirtuin-NAD+ connection is one of the central mechanisms linking aging to cellular dysfunction.

SIRT1 is the most studied sirtuin and is associated with the benefits of caloric restriction — one of the most robust interventions for extending lifespan in multiple species. Caloric restriction increases NAD+ levels, which activates SIRT1, which promotes cellular repair and improves metabolic efficiency. This same pathway can be activated by NAD+ precursor supplementation without the caloric restriction, which is one reason NAD+ precursors have generated so much research interest in the field of longevity science.

SIRT3 and SIRT4 are mitochondrial sirtuins that regulate mitochondrial function directly. SIRT3 promotes the function of enzymes involved in fatty acid oxidation and the electron transport chain. SIRT4 regulates glutamate dehydrogenase and insulin secretion. These mitochondrial sirtuins are particularly relevant for metabolic health — their decline with age and NAD+ depletion contributes to the mitochondrial dysfunction that characterises metabolic syndrome and age-related metabolic decline.

NMN vs NR: Comparing the Precursors

Both nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR) are NAD+ precursors — they are molecules that the body converts to NAD+ through different biochemical pathways. NMN is one step closer to NAD+ in the biosynthetic pathway — it is directly converted to NAD+ by the enzyme NMNAT. NR must first be converted to NMN before becoming NAD+. This does not necessarily make NMN superior to NR — the bioavailability and tissue distribution of both molecules depend on multiple factors beyond their position in the biosynthetic pathway.

Human trials on both NMN and NR have shown that both elevate NAD+ levels in blood and tissues. There is more human clinical data on NMN for metabolic parameters (blood glucose, insulin sensitivity, physical performance) and more human clinical data on NR for safety and bioavailability. Both are reasonable choices for NAD+ precursor supplementation. The most evidence-based stacks combine NAD+ precursors with other mitochondrial support nutrients — CoQ10, PQQ, alpha-lipoic acid — because mitochondrial function depends on multiple cofactors, not just NAD+.